Results 61 to 70 of about 98,340 (384)
End‐to‐end collaboration to transform biopharmaceutical development and manufacturing
Biotechnology and Bioengineering, 2021 An ambitious 10‐year collaborative program is described to invent, design, demonstrate, and support commercialization of integrated biopharmaceutical manufacturing technology intended to transform the industry.
J. Erickson +23 more
semanticscholar +1 more source
The rise of companies from emerging markets in global health governance: opportunities and challenges [PDF]
, 2014 The article analyses the involvement of pharmaceutical companies from emerging markets in global health governance. It finds that they play a central role as low-cost suppliers of medicines and vaccines and, increasingly, new technologies.
ANNE ROEMER-MAHLER +23 more
core +1 more source
Developments and opportunities in continuous biopharmaceutical manufacturing
mAbs, 2021 Today’s biologics manufacturing practices incur high costs to the drug makers, which can contribute to high prices for patients. Timely investment in the development and implementation of continuous biomanufacturing can increase the production of ...
Ohnmar Khanal, A. Lenhoff
semanticscholar +1 more source
Whole-cell Escherichia coli lactate biosensor for monitoring mammalian cell cultures during biopharmaceutical production [PDF]
, 2017 Many high-value added recombinant proteins, such as therapeutic glycoproteins, are produced using mammalian cell cultures. In order to optimise the productivity of these cultures it is important to monitor cellular metabolism, for example the utilisation
Ainsworth, C +5 more
core +1 more source
Microbiology Spectrum, 2014 ABSTRACTPlasmids are currently an indispensable molecular tool in life science research and a central asset for the modern biotechnology industry, supporting its mission to produce pharmaceutical proteins, antibodies, vaccines, industrial enzymes, and molecular diagnostics, to name a few key products.
Duarte Miguel F, Prazeres +1 more
openaire +2 more sources
Harnessing Macrophages for Controlled-Release Drug Delivery: Lessons From Microbes
Frontiers in Pharmacology, 2019 With the effectiveness of therapeutic agents ever decreasing and the increased incidence of multi-drug resistant pathogens, there is a clear need for administration of more potent, potentially more toxic, drugs. Alternatively, biopharmaceuticals may hold
Johan Georg Visser +2 more
doaj +1 more source
Control strategy for biopharmaceutical production by model predictive control
Biotechnology progress (Print)The biopharmaceutical industry is rapidly advancing, driven by the need for cutting‐edge technologies to meet the growing demand for life‐saving treatments.
T. Eslami, Alois Jungbauer
semanticscholar +1 more source
Analytical and Bioanalytical Chemistry, 2020 As competition in the biopharmaceutical market gets keener due to the market entry of biosimilars, process analytical technologies (PATs) play an important role for process automation and cost reduction.
Laura Rolinger +2 more
semanticscholar +1 more source
Determinants of biopharmaceutical R&D expenditures in China: the impact of spatiotemporal context
Scientometrics, 2021 The spatiotemporal context affects corporate behavior because any corporate activity is carried out in a specific time and space. Based on an examination on the research and development (R&D) expenditures of 284 listed biopharmaceutical companies in ...
Jiafeng Gu
semanticscholar +1 more source
DEVELOPMENT PROSPECTS OF BIOPHARMACEUTICAL PLANTS IN PALEMBANG CITY
Biovalentia: Biological Research Journal, 2021 Biopharmaceutical plants or medicinal plants are plants grown in the garden that have medicinal properties. The types of biopharmaceutical plants have been cultivated for more than 5 years and are managed by the people of Palembang City who are members ...
Meri Ariyantini +2 more
doaj +1 more source